Literature DB >> 18203834

Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity.

Sheng-Mei Jiang1, Nadeeza Ishmael, Julie Dunning Hotopp, Manuela Puliti, Luciana Tissi, Nikhil Kumar, Michael J Cieslewicz, Hervé Tettelin, Michael R Wessels.   

Abstract

CsrRS (or CovRS) is a two-component regulatory system that controls expression of multiple virulence factors in the important human pathogen group B Streptococcus (GBS). We now report global gene expression studies in GBS strains 2603V/R and 515 and their isogenic csrR and csrS mutants. Together with data reported previously for strain NEM316, the results reveal a conserved 39-gene CsrRS regulon. In vitro phosphorylation-dependent binding of recombinant CsrR to promoter regions of both positively and negatively regulated genes suggests that direct binding of CsrR can mediate activation as well as repression of target gene expression. Distinct patterns of gene regulation in csrR versus csrS mutants in strain 2603V/R compared to 515 were associated with different hierarchies of relative virulence of wild-type, csrR, and csrS mutants in murine models of systemic infection and septic arthritis. We conclude that CsrRS regulates a core group of genes including important virulence factors in diverse strains of GBS but also displays marked variability in the repertoire of regulated genes and in the relative effects of CsrS signaling on CsrR-mediated gene regulation. Such variation is likely to play an important role in strain-specific adaptation of GBS to particular host environments and pathogenic potential in susceptible hosts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203834      PMCID: PMC2258897          DOI: 10.1128/JB.01677-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  Primer3 on the WWW for general users and for biologist programmers.

Authors:  S Rozen; H Skaletsky
Journal:  Methods Mol Biol       Date:  2000

2.  Gene expression analysis of the Streptococcus pneumoniae competence regulons by use of DNA microarrays.

Authors:  S Peterson; R T Cline; H Tettelin; V Sharov; D A Morrison
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

Review 3.  Two-component signal transduction.

Authors:  A M Stock; V L Robinson; P N Goudreau
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

4.  TM4: a free, open-source system for microarray data management and analysis.

Authors:  A I Saeed; V Sharov; J White; J Li; W Liang; N Bhagabati; J Braisted; M Klapa; T Currier; M Thiagarajan; A Sturn; M Snuffin; A Rezantsev; D Popov; A Ryltsov; E Kostukovich; I Borisovsky; Z Liu; A Vinsavich; V Trush; J Quackenbush
Journal:  Biotechniques       Date:  2003-02       Impact factor: 1.993

5.  Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae.

Authors:  Lakshmi Rajagopal; Anthony Vo; Aurelio Silvestroni; Craig E Rubens
Journal:  Mol Microbiol       Date:  2006-09-27       Impact factor: 3.501

6.  Repression of virulence genes by phosphorylation-dependent oligomerization of CsrR at target promoters in S. pyogenes.

Authors:  A A Miller; N C Engleberg; V J DiRita
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

7.  Involvement of the adc operon and manganese homeostasis in Streptococcus gordonii biofilm formation.

Authors:  C Y Loo; K Mitrakul; I B Voss; C V Hughes; N Ganeshkumar
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

8.  Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling.

Authors:  Morag R Graham; Laura M Smoot; Cristi A Lux Migliaccio; Kimmo Virtaneva; Daniel E Sturdevant; Stephen F Porcella; Michael J Federle; Gerald J Adams; June R Scott; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

9.  Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.

Authors:  Herve Tettelin; Vega Masignani; Michael J Cieslewicz; Jonathan A Eisen; Scott Peterson; Michael R Wessels; Ian T Paulsen; Karen E Nelson; Immaculada Margarit; Timothy D Read; Lawrence C Madoff; Alex M Wolf; Maureen J Beanan; Lauren M Brinkac; Sean C Daugherty; Robert T DeBoy; A Scott Durkin; James F Kolonay; Ramana Madupu; Matthew R Lewis; Diana Radune; Nadezhda B Fedorova; David Scanlan; Hoda Khouri; Stephanie Mulligan; Heather A Carty; Robin T Cline; Susan E Van Aken; John Gill; Maria Scarselli; Marirosa Mora; Emilia T Iacobini; Cecilia Brettoni; Giuliano Galli; Massimo Mariani; Filippo Vegni; Domenico Maione; Daniela Rinaudo; Rino Rappuoli; John L Telford; Dennis L Kasper; Guido Grandi; Claire M Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-28       Impact factor: 11.205

10.  Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease.

Authors:  Philippe Glaser; Christophe Rusniok; Carmen Buchrieser; Fabien Chevalier; Lionel Frangeul; Tarek Msadek; Mohamed Zouine; Elisabeth Couvé; Lila Lalioui; Claire Poyart; Patrick Trieu-Cuot; Frank Kunst
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501

View more
  46 in total

1.  Regulation and function of pilus island 1 in group B streptococcus.

Authors:  Shengmei Jiang; Su Eun Park; Puja Yadav; Lawrence C Paoletti; Michael R Wessels
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

2.  CovR alleviates transcriptional silencing by a nucleoid-associated histone-like protein in Streptococcus mutans.

Authors:  Indranil Biswas; Saswat Sourav Mohapatra
Journal:  J Bacteriol       Date:  2012-02-17       Impact factor: 3.490

3.  A Hyperhemolytic/Hyperpigmented Group B Streptococcus Strain with a CovR Mutation Isolated from an Adolescent Patient with Sore Throat.

Authors:  Christopher Whidbey; Kellie Burnside; Raquel M Martinez; Claire Gendrin; Jay Vornhagen; Andrew Frando; Maria Isabel Harrell; Ryan McAdams; Lakshmi Rajagopal
Journal:  Clin Res Infect Dis       Date:  2015-09-03

Review 4.  Two-Component Signal Transduction Systems in the Human Pathogen Streptococcus agalactiae.

Authors:  Lamar Thomas; Laura Cook
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

5.  CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development.

Authors:  Isabella Santi; Renata Grifantini; Sheng-Mei Jiang; Cecilia Brettoni; Guido Grandi; Michael R Wessels; Marco Soriani
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

Review 6.  The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent Pathogen.

Authors:  Blair Armistead; Elizabeth Oler; Kristina Adams Waldorf; Lakshmi Rajagopal
Journal:  J Mol Biol       Date:  2019-01-31       Impact factor: 5.469

7.  Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR.

Authors:  Wan-Jung Lin; Don Walthers; James E Connelly; Kellie Burnside; Kelsea A Jewell; Linda J Kenney; Lakshmi Rajagopal
Journal:  Mol Microbiol       Date:  2009-01-23       Impact factor: 3.501

8.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

9.  Inactivation of DNA-binding response regulator Sak189 abrogates beta-antigen expression and affects virulence of Streptococcus agalactiae.

Authors:  Anastasia S Rozhdestvenskaya; Artem A Totolian; Alexander V Dmitriev
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

10.  Serotype- and strain- dependent contribution of the sensor kinase CovS of the CovRS two-component system to Streptococcus pyogenes pathogenesis.

Authors:  Venelina Sugareva; Regina Arlt; Tomas Fiedler; Catur Riani; Andreas Podbielski; Bernd Kreikemeyer
Journal:  BMC Microbiol       Date:  2010-02-01       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.